Trial intelligence / Profile preview

Adherence to Once vs Twice Daily Tacrolimus in Renal Transplant

NCT01334333Phase 4Completed

Sponsor
University of British Columbia
Start
Nov 2011
Primary completion
Oct 2014
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by University of British Columbia. Started Nov 2011; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT01334333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01334333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call